Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advance Evero™ 18 Everolimus-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter Versus Paclitaxel-coated Ballons in Patients With Femoropopliteal Disease (EVERO Trial)

NCT07144150 is registered in ClinicalTrials.gov with Cook Research Incorporated as lead sponsor.

NCT NCT07144150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07144150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advance Evero™ 18 Everolimus-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter Versus Paclitaxel-coated Ballons in Patients With Femoropopliteal Disease (EVERO Trial)
Lead sponsor
Cook Research Incorporated
Phase
Not applicable
Overall status
Recruiting
Start date
April 17, 2026
Completion date
October 31, 2032
Enrollment
410 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease, peripheral vascular disease